VanEck Pharmaceutical ETF
PPH
#1350
ETF rank
C$1.33 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$153.79
Share price
-0.59%
Change (1 day)
28.03%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of August 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of August 2026: 0.36%